AvantGuard Awarded $2.65 Million in NIH Grants to Advance Next-Generation Antimicrobial Technologies
ITHACA, N.Y.–(BUSINESS WIRE)–AvantGuard, Inc., a biotechnology company developing next-generation antimicrobial technologies inspired by the human immune system, today announced it has received three National Institutes of Health (NIH) research grants totaling $2.65 million. The awards…